Complex antioxidants in a randomized single-blinded study of memory in seniors
Oxidative injury to the brain and aging are theoretical co-causes of Alzheimer’s Disease (AD). Amyloid plaques and tangles are then secondary phenomenon. The preclinical state would then be ‘normal’ elderly.
A potent complex antioxidant (antiOx) was tested against a popular one-a-day multivitamin (mV) in a randomized single blind design in ‘normal’ senior subjects over 6 months. Memory testing was done at baseline, 1, 3, and 6 months. The generalized estimating equation (GEE) approach was used to compare the change score of NLT100 and 20WR between two groups over time.
Analysis of the antiOx group (30 subjects) demonstrated significant improvement in declarative memory (change score for NLT100 at month 6 = 6.36 p < 0.0001) and working memory (change score for 20WR at month 6 = 3.23, p < 0.0001). A change-score analysis over 6 months suggests possible neurogenesis in the antiOx group. The mV group (33 subjects) had a change score of the NLT100 and 20WR on the sixth month of 2.20 and 0.32 (p = 0.07, 0.35).
A complex antioxidant blend, sold as an over-the-counter (OTC) supplement, can improve memory in elder subjects. Antioxidants may be beneficial in AD and other neurodegerative diseases.
KeywordsAntioxidants Memory improvement Aging Alzheimers Pathophysiology of Alzheimer’s
Benign senile forgetfulness
Generalized estimating equation
Mild cognitive impairment
Mini-mental status examination
100 item names-learning paired association test
20 word-recall test
Financial support for this research was obtained from Solo Non-Profit Research, Ltd. Interviews of the subjects were conducted at the offices of Alzheimer’s Corporation, 6000 Uptown Blvd, Suite 308, Albuquerque, NM 87110.
All authors significantly contributed to this work. WKS designed and coordinated the study, performed structured interviews, and drafted the manuscript. RLM coordinated the study and performed structured interviews. BP coordinated the blind randomization of subjects and direct communication with subjects about blinded issues. GMM and YL participated in the design of the study and performed statistical analysis of data. All authors read and approved the manuscript.
Compliance with ethical standards
Conflict of interest
GMM, YL, and BP have no conflicts to report. WKS is a stockholder and unpaid officer of Alzheimer’s Corporation. RLM is an employee of Alzheimer’s Corporation.
The experimental protocol was in compliance with guidelines on human experimentation. The entire study protocol was approved by Ethical and Independent Review Services (Independence, MO 64055).
After explanation of the protocol to a subject, written informed consent was obtained.
- 8.Papandreou MA, Dimakopoulou A, Linardaki ZI, Cordopatis P, Klimis-Zacas D, Margarity M, Lamari FN (2009) Effect of polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity. Behav Brain Res 198:352–358CrossRefPubMedGoogle Scholar
- 11.Dixit S, Harrison FE (2014) The protective role of vitamin C against Alzheimer’s disease. Society for Neuroscience annual meeting (Washington, DC) Poster 528.17Google Scholar
- 13.Summers WK (2011) Current & future treatments of memory complaints and Alzheimer’s disease. Ther Future Med 8:481–504Google Scholar
- 16.Scheltens P, Twisk JWR, Blesa R, Scarpini E, von Arnim CA, Bongers A, Harrison J, Swinkels SH, Stam CJ, deWaal H, Wurtman RJ, Wieggers RL, Vellas B, Kamphuis PJ (2012) Efficacy of Souvenaid in mild Alzheimer’s disease: results from a randomized controlled trial. J Alzheimers Dis 31:225–236PubMedGoogle Scholar
- 19.Halliwell B, Gutteridge JMC (2001) Free Radicals in Biology and Medicine, 3rd edn. Oxford University Press, Oxford, pp 105–245Google Scholar
- 21.Comparator Supplements http://www.MemoryreVITALIZER.com. Accessed 05 Apr 2012
- 22.Comparator Supplement http://www.centrum.com/centrum-silver-adults-50-plus. Accessed 05 Apr 2012
- 30.https://en.wikipedia.org/wiki/Tower_of_Hanoi. Accessed 22 Feb 2017
- 36.Pramastya H, Anggadiredja K, Fidriany I (2010) Neuroprotective effect of gotu kola (centella asiatica L urban) in cerebral ischemic rat model. In: Proceeding 3rd International Conference on Mathematical Natural Science 77–90Google Scholar